Related Experiment Video
Updated: Mar 9, 2026
09:08
Precision Cut Lung Slices as an Efficient Tool for Ex vivo Pulmonary Vessel Structure and Contractility Studies
Published on: May 24, 2021
7.1K
Endocan and the respiratory system: a review
Maria Kechagia1, Ioannis Papassotiriou2, Konstantinos I Gourgoulianis3
1Respiratory Medicine Department, University of Thessaly Medical School, Larissa; Department of Clinical Biochemistry, Aghia Sophia Children's Hospital, Athens, Greece.
International Journal of Chronic Obstructive Pulmonary Disease
|December 23, 2016
Summary
Endocan, a biomarker reflecting endothelial dysfunction, is increasingly studied for its prognostic value. Research highlights its potential in respiratory diseases, including malignant, inflammatory, and obstructive conditions.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathophysiology
Background:
- Endocan (endothelial cell-specific molecule 1) is an endothelial proteoglycan.
- It is upregulated by proangiogenic and pro-inflammatory factors.
- Endocan indicates endothelial activation and dysfunction, serving as a biomarker.
Purpose of the Study:
- To review current scientific knowledge on endocan.
- To emphasize its potential clinical value as a prognostic marker.
- To focus on respiratory system disorders.
Main Methods:
- Literature review of scientific studies on endocan.
- Analysis of data linking endocan to endothelial activation and dysfunction.
- Evaluation of endocan's role in various pathophysiological processes.
Main Results:
- Endocan is expressed by renal and pulmonary endothelium.
- Its levels correlate with endothelial activation and dysfunction.
- Evidence suggests prognostic value in respiratory diseases.
Conclusions:
- Endocan is a relevant biomarker for endothelial status.
- It holds potential as a prognostic marker in respiratory malignancies, inflammation, and obstructive disorders.
- Further research is warranted to fully establish its clinical utility.
